BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36916108)

  • 1. Sympathetic ophthalmia in an 85-year-old female and a 90-year-old male after a non-complicated cataract surgery: a case report.
    Muto T; Machida S; Imaizumi S
    J Int Med Res; 2023 Mar; 51(3):3000605231160945. PubMed ID: 36916108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyper-Reflective Outer Nuclear Layer (HONL) in Vogt-Koyanagi-Harada Disease and Sympathetic Ophthalmia.
    Fonollosa A; Charcán I; Giralt L; Artaraz J; Soto A; Ruiz-Arruza I; Agarwal A
    Ocul Immunol Inflamm; 2024 May; 32(4):419-423. PubMed ID: 36332138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Clinical Features and Visual Outcome between Sympathetic Ophthalmia and Vogt-Koyanagi-Harada Disease in Chinese Patients.
    Yang P; Liu S; Zhong Z; Du L; Ye Z; Zhou W; Kijlstra A
    Ophthalmology; 2019 Sep; 126(9):1297-1305. PubMed ID: 30959067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sympathetic ophthalmia after 27-G pars plana vitrectomy.
    Takai Y; Sakanishi Y; Okamoto M; Ebihara N
    BMC Ophthalmol; 2021 May; 21(1):195. PubMed ID: 33934701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal Pigment Epithelium Detachment in Acute Vogt-Koyanagi-Harada Disease: An Unusual Finding at Presentation.
    Khochtali S; Ksiaa I; Megzari K; Khairallah M
    Ocul Immunol Inflamm; 2019; 27(4):591-594. PubMed ID: 29513616
    [No Abstract]   [Full Text] [Related]  

  • 6. Outcome and Prognostic Factors of Phacoemulsification Cataract Surgery in Vogt-Koyanagi-Harada Uveitis.
    Ji Y; Hu K; Li C; Li P; Kijlstra A; Eghrari AO; Lei B; Du L; Wan W; Yang P
    Am J Ophthalmol; 2018 Dec; 196():121-128. PubMed ID: 30194930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vogt-Koyanagi-Harada syndrome (uveomeningoencephalitic syndrome).
    Manethova K; Ernest J; Hrevus M
    Eur J Ophthalmol; 2017 Jan; 27(1):e5-e8. PubMed ID: 28009404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sympathetic ophthalmia versus Harada disease].
    Vanheesbeke A; Rasquin F; Cordonnier M; Schrooyen M; Dargent JL
    Bull Soc Belge Ophtalmol; 1996; 262():81-92. PubMed ID: 9376925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sympathetic Ophthalmia - a Contribution to Immunology, Clinic and Current Imaging.
    Rua D; Pohlmann D; Pleyer U
    Klin Monbl Augenheilkd; 2020 Sep; 237(9):1060-1069. PubMed ID: 32967030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sympathetic Ophthalmia: Demographic Characteristics, Clinical Findings, and Treatment Results.
    Özdemir Yalçınsoy K; Özdamar Erol Y; Çakar Özdal P
    Turk J Ophthalmol; 2023 Feb; 53(1):23-29. PubMed ID: 36847630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between retinal lesions and inward choroidal bulging in Vogt-Koyanagi-Harada disease.
    Hosoda Y; Uji A; Hangai M; Morooka S; Nishijima K; Yoshimura N
    Am J Ophthalmol; 2014 May; 157(5):1056-63. PubMed ID: 24491415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sympathetic ophthalmia : Therapy with steroid-free immunosuppressant azathioprine].
    Wand K; Straub M; Lohmann CP; Mayer CS
    Ophthalmologe; 2016 Oct; 113(10):867-869. PubMed ID: 26879557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sympathetic ophthalmia after surgical resection of iridociliary melanoma. A case report.
    Garcia-Arumi J; Montolio Gil M; Morral Palau M; Segura Garcia A
    Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1353-6. PubMed ID: 16523295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case Report of a 4-Year-Old Child with Complicated Vogt-Koyanagi-Harada at a Tertiary Eye Hospital.
    AlQahtani DS; Al Shamrani M
    Middle East Afr J Ophthalmol; 2019; 26(2):117-119. PubMed ID: 31543672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case with metastatic cutaneous malignant melanoma that developed Vogt-Koyanagi-Harada-like uveitis following pembrolizumab treatment.
    Enomoto H; Kato K; Sugawara A; Itabashi M; Kondo M
    Doc Ophthalmol; 2021 Jun; 142(3):353-360. PubMed ID: 33392895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients.
    Yang P; Ren Y; Li B; Fang W; Meng Q; Kijlstra A
    Ophthalmology; 2007 Mar; 114(3):606-14. PubMed ID: 17123618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for poor visual outcome following cataract surgery in Vogt-Koyanagi-Harada disease.
    Quek DT; Jap A; Chee SP
    Br J Ophthalmol; 2011 Nov; 95(11):1542-6. PubMed ID: 21349937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vogt-Koyanagi-Harada Disease-Like Uveitis during Nivolumab (Anti-PD-1 Antibody) Treatment for Metastatic Cutaneous Malignant Melanoma.
    Obata S; Saishin Y; Teramura K; Ohji M
    Case Rep Ophthalmol; 2019; 10(1):67-74. PubMed ID: 31097947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A severe case of sympathetic ophthalmia--case report].
    Matysik-Woźniak A; Katski W; Lewandowska-Furmanik M; Zarnowski T; Pawłowska-Wakowicz B
    Klin Oczna; 2009; 111(10-12):343-5. PubMed ID: 20169892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal bevacizumab injection for persistent serous retinal detachment associated with Vogt-Koyanagi-Harada disease.
    Park HS; Nam KY; Kim JY
    Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):133-6. PubMed ID: 20689964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.